Envoy Medical terminated its At The Market Offering Agreement on June 24, 2026. The agreement, originally executed on January 17, 2025, is being ended early at the company’s discretion. No termination fees were disclosed. The move indicates a shift in the company’s capital-raising approach.
Agreement details:
- Agreement terminated: At The Market Offering Agreement
- Original agreement date: Jan 17 2025
- Termination date: Jun 24 2026
- Termination type: Early
- Exit fees / payments: None
- Reason: Discontinue ATM equity program
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.